{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:53:16Z","timestamp":1792511596596,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2020\/39\/B\/NZ7\/02901"],"award-info":[{"award-number":["UMO-2020\/39\/B\/NZ7\/02901"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52495-7","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:07:41Z","timestamp":1778598461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ethanolic extract of Polish Propolis exhibits synergy with selected antifungal agents against yeast pathogens causing candidiasis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-1167","authenticated-orcid":false,"given":"Piotr","family":"Bollin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5548-8216","authenticated-orcid":false,"given":"Micha\u0142 K.","family":"Piera\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7368-1076","authenticated-orcid":false,"given":"Piotr Marek","family":"Ku\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1542-897X","authenticated-orcid":false,"given":"Patrick","family":"Van Dijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8291-5148","authenticated-orcid":false,"given":"Piotr","family":"Szweda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"52495_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012055","volume":"20","author":"DW Denning","year":"2024","unstructured":"Denning, D. W. Renaming Candida glabrata\u2014A case of taxonomic purity over clinical and public health pragmatism. PLoS Pathog. 20, e1012055 (2024).","journal-title":"PLoS Pathog."},{"key":"52495_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3314\/mmj.22.004","volume":"63","author":"M Takashima","year":"2022","unstructured":"Takashima, M. & Sugita, T. Taxonomy of Pathogenic Yeasts Candida, Cryptococcus, Malassezia, and Trichosporon. Med. Mycol. J. 63, 119\u2013132 (2022).","journal-title":"Med. Mycol. J."},{"key":"52495_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007138","volume":"14","author":"AP Douglass","year":"2018","unstructured":"Douglass, A. P. et al. Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: One species, four names. PLoS Pathog. 14, e1007138 (2018).","journal-title":"PLoS Pathog."},{"key":"52495_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3767\/persoonia.2024.52.02","volume":"52","author":"F Liu","year":"2024","unstructured":"Liu, F. et al. Phylogenomic analysis of the Candida auris-Candida haemuli clade and related taxa in the Metschnikowiaceae, and proposal of thirteen new genera, fifty-five new combinations and nine new species. Persoonia 52, 22\u201343 (2024).","journal-title":"Persoonia"},{"key":"52495_CR5","first-page":"52","volume":"51","author":"SX Zhang","year":"2025","unstructured":"Zhang, S. X. et al. Reaffirming the importance of nomenclature stability for Candida auris and its associated disease of candidiasis. J. Clin. Microbiol. 51, 52 (2025).","journal-title":"J. Clin. Microbiol."},{"key":"52495_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11046-024-00871-0","volume":"189","author":"S Wolfgruber","year":"2024","unstructured":"Wolfgruber, S. et al. Insights from three Pan-European multicentre studies on invasive Candida infections and outlook to ECMM Candida IV. Mycopathologia 189, 70 (2024).","journal-title":"Mycopathologia"},{"key":"52495_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/mmy\/myaa031","volume":"59","author":"AT Jamiu","year":"2021","unstructured":"Jamiu, A. T., Albertyn, J., Sebolai, O. M. & Pohl, C. H. Update on Candida krusei, a potential multidrug-resistant pathogen. Med. Mycol. 59, 14\u201330 (2021).","journal-title":"Med. Mycol."},{"key":"52495_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13054-019-2449-y","volume":"23","author":"A Cortegiani","year":"2019","unstructured":"Cortegiani, A., Misseri, G., Giarratano, A., Bassetti, M. & Eyre, D. The global challenge of Candida auris in the intensive care unit. Crit. Care 23, 150 (2019).","journal-title":"Crit. Care"},{"key":"52495_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006290","author":"A Chowdhary","year":"2017","unstructured":"Chowdhary, A., Sharma, C. & Meis, J. F. Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1006290 (2017).","journal-title":"PLoS Pathog."},{"key":"52495_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev-med-061523-021233","volume":"76","author":"EF Eix","year":"2025","unstructured":"Eix, E. F. & Nett, J. E. Candida auris: Epidemiology and antifungal strategy. Annu. Rev. Med. 76, 57\u201367 (2025).","journal-title":"Annu. Rev. Med."},{"key":"52495_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/jof9020171","volume":"9","author":"G Vanreppelen","year":"2023","unstructured":"Vanreppelen, G., Wuyts, J., Van Dijck, P. & Vandecruys, P. Sources of antifungal drugs. J. Fungi 9, 171 (2023).","journal-title":"J. Fungi"},{"key":"52495_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00142-23","author":"E Puumala","year":"2024","unstructured":"Puumala, E., Fallah, S., Robbins, N. & Cowen, L. E. Advancements and challenges in antifungal therapeutic development. Clin. Microbiol. Rev. https:\/\/doi.org\/10.1128\/cmr.00142-23 (2024).","journal-title":"Clin. Microbiol. Rev."},{"key":"52495_CR13","doi-asserted-by":"crossref","unstructured":"Silva-Carvalho, R., Baltazar, F., & Almeida-Aguiar, C. Propolis: A complex natural product with a plethora of biological activities that can be explored for drug development. 2015, 206439 (2015).","DOI":"10.1155\/2015\/206439"},{"key":"52495_CR14","doi-asserted-by":"publisher","first-page":"19610","DOI":"10.3390\/molecules191219610","volume":"19","author":"S Huang","year":"2014","unstructured":"Huang, S., Zhang, C. P., Wang, K., Li, G. Q. & Hu, F. L. Recent advances in the chemical composition of propolis. Mol. 19, 19610\u201319632 (2014).","journal-title":"Mol."},{"key":"52495_CR15","first-page":"1869","volume":"10","author":"P Ristivojevi\u0107","year":"2015","unstructured":"Ristivojevi\u0107, P., Trifkovi\u0107, J., Andri\u0107, F. & Milojkovi\u0107-Opsenica, D. Poplar-type propolis: Chemical composition, botanical origin and biological activity. Nat. Prod. Commun. 10, 1869\u20131876 (2015).","journal-title":"Nat. Prod. Commun."},{"key":"52495_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/DER.0000000000000011","volume":"24","author":"AC de Groot","year":"2013","unstructured":"de Groot, A. C. Propolis. Dermatitis 24, 263\u2013282 (2013).","journal-title":"Dermatitis"},{"key":"52495_CR17","doi-asserted-by":"crossref","unstructured":"Bava, R. et al. Hive products: Composition, pharmacological properties, and therapeutic applications. Pharmaceuticals 17\u00a0(2024).","DOI":"10.3390\/ph17050646"},{"key":"52495_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.11.063","volume":"29","author":"S Bouchelaghem","year":"2021","unstructured":"Bouchelaghem, S. Propolis characterization and antimicrobial activities against Staphylococcus aureus and Candida albicans: A review. Saudi J. Biol. Sci. 29, 1936 (2021).","journal-title":"Saudi J. Biol. Sci."},{"key":"52495_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/microorganisms10020364","volume":"10","author":"M O\u017carowski","year":"2022","unstructured":"O\u017carowski, M., Karpi\u0144ski, T. M., Alam, R. & \u0141ochy\u0144ska, M. Antifungal properties of chemically defined propolis from various geographical regions. Microorg 10, 364 (2022).","journal-title":"Microorg"},{"key":"52495_CR20","first-page":"225","volume-title":"Advances in Experimental Medicine and Biology","author":"F Gharibpour","year":"2021","unstructured":"Gharibpour, F. et al. The effects of nutraceuticals and herbal medicine on Candida albicans in Oral Candidiasis: A comprehensive review. In Advances in Experimental Medicine and Biology Vol. 1308 225\u2013248 (Springer, 2021)."},{"key":"52495_CR21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas, P. G. et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 62, e1\u2013e50 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"52495_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jof8101077","volume":"8","author":"S Fioriti","year":"2022","unstructured":"Fioriti, S. et al. Antifungal combinations against Candida species: From bench to bedside. J. Fungi 8, 1077 (2022).","journal-title":"J. Fungi"},{"key":"52495_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.876183","volume":"13","author":"S Hossain","year":"2022","unstructured":"Hossain, S., Yousaf, M., Liu, Y., Chang, D. & Zhou, X. An overview of the evidence and mechanism of drug\u2013herb interactions between propolis and pharmaceutical drugs. Front. Pharmacol. 13, 876183 (2022).","journal-title":"Front. Pharmacol."},{"key":"52495_CR24","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1128\/JCM.01121-14","volume":"52","author":"CD Doern","year":"2014","unstructured":"Doern, C. D. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J. Clin. Microbiol. 52, 4124\u20134128 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"52495_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4103\/ijmm.IJMM_17_189","volume":"35","author":"S Laishram","year":"2017","unstructured":"Laishram, S., Pragasam, A., Bakthavatchalam, Y. & Veeraraghavan, B. An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies. Indian J. Med. Microbiol. 35, 445\u2013468 (2017).","journal-title":"Indian J. Med. Microbiol."},{"key":"52495_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00930","volume":"9","author":"A Wozniak","year":"2018","unstructured":"Wozniak, A. & Grinholc, M. Combined antimicrobial activity of photodynamic inactivation and antimicrobials\u2013state of the art. Front. Microbiol. 9, 368327 (2018).","journal-title":"Front. Microbiol."},{"key":"52495_CR27","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","volume":"40","author":"RL White","year":"1996","unstructured":"White, R. L., Burgess, D. S., Manduru, M. & Bosso, J. A. Comparison of three different in vitro methods of detecting synergy: Time-kill, checkerboard, and E test. Antimicrob. Agents Chemother. 40, 1914 (1996).","journal-title":"Antimicrob. Agents Chemother."},{"key":"52495_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/jac\/49.2.345","volume":"49","author":"RE Lewis","year":"2002","unstructured":"Lewis, R. E., Diekema, D. J., Messer, S. A., Pfaller, M. A. & Klepser, M. E. Comparison of Etest, chequerboard dilution and time\u2013kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J. Antimicrob. Chemother. 49, 345\u2013351 (2002).","journal-title":"J. Antimicrob. Chemother."},{"key":"52495_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/pca.2544","volume":"26","author":"P Ristivojevi\u0107","year":"2015","unstructured":"Ristivojevi\u0107, P. et al. Ultrahigh-performance liquid chromatography and mass spectrometry (UHPLC\u2013LTQ\/Orbitrap\/MS\/MS) study of phenolic profile of Serbian poplar type propolis. Phytochem. Anal. 26, 127\u2013136 (2015).","journal-title":"Phytochem. Anal."},{"key":"52495_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.foodchem.2013.07.032","volume":"142","author":"VA Isidorov","year":"2014","unstructured":"Isidorov, V. A., Szczepaniak, L. & Bakier, S. Rapid GC\/MS determination of botanical precursors of Eurasian propolis. Food Chem. 142, 101\u2013106 (2014).","journal-title":"Food Chem."},{"key":"52495_CR31","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/molecules23061262","volume":"23","author":"P Okinczyc","year":"2018","unstructured":"Okinczyc, P. et al. Profile of polyphenolic and essential oil composition of polish propolis, black poplar and aspens buds. Mol 23, 1262 (2018).","journal-title":"Mol"},{"key":"52495_CR32","doi-asserted-by":"publisher","first-page":"119799","DOI":"10.1016\/j.jep.2025.119799","volume":"347","author":"P Bollin","year":"2025","unstructured":"Bollin, P., Ku\u015b, P. M., Oki\u0144czyc, P., Van Dijck, P. & Szweda, P. Identification of potential markers of elevated anticandidal activity of propolis extracts. J. Ethnopharmacol. 347, 119799 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"52495_CR33","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/molecules24091732","volume":"24","author":"K Grecka","year":"2019","unstructured":"Grecka, K. et al. The anti-staphylococcal potential of ethanolic polish propolis extracts. Mol 24, 1732 (2019).","journal-title":"Mol"},{"key":"52495_CR34","doi-asserted-by":"crossref","unstructured":"Jenny, J. C., Ku\u015b, P. M. & Szweda, P. Investigation of antifungal and antibacterial potential of green extracts of propolis. 14\u00a0(2024).","DOI":"10.1038\/s41598-024-64111-7"},{"key":"52495_CR35","first-page":"215","volume":"13","author":"K Grecka","year":"2021","unstructured":"Grecka, K. & Szweda, P. Synergistic effects of propolis combined with 2-phenoxyethanol and antipyretics on the growth of Staphylococcus aureus. Pharm 13, 215 (2021).","journal-title":"Pharm"},{"key":"52495_CR36","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1128\/JCM.00248-12","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller, M. A. et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI Broth microdilution. J. Clin. Microbiol. 50, 2040\u20132046 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"52495_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/11585270-000000000-00000","volume":"71","author":"SCA Chen","year":"2011","unstructured":"Chen, S. C. A., Slavin, M. A. & Sorrell, T. C. Echinocandin antifungal drugs in fungal infections. Drugs 71, 11\u201341 (2011).","journal-title":"Drugs"},{"key":"52495_CR38","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE Pristov","year":"2019","unstructured":"Pristov, K. E. & Ghannoum, M. A. Resistance of Candida to azoles and echinocandins worldwide. Clin. Microbiol. Infect. 25, 792\u2013798 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"52495_CR39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/1120009X.1994.11741156","volume":"6","author":"MP Arevalo","year":"1994","unstructured":"Arevalo, M. P., Arias, A., Andreu, A., Rodriguez, C. & Sierra, A. Fluconazole, itraconazole and ketoconazole in vitro activity against Candida spp. J. Chemother. 6, 226\u2013229 (1994).","journal-title":"J. Chemother."},{"key":"52495_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1079-2104(99)70293-3","volume":"87","author":"G Giuliana","year":"1999","unstructured":"Giuliana, G., Pizzo, G., Milici, M. E. & Giangreco, R. In vitro activities of antimicrobial agents against Candida species. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontology 87, 44\u201349 (1999).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontology"},{"key":"52495_CR41","doi-asserted-by":"publisher","first-page":"e18719","DOI":"10.1590\/s2175-97902022e18719","volume":"58","author":"ML Meneses","year":"2022","unstructured":"Meneses, M. L., Recalde, M., Martin, P. L. & Pardo, A. G. Antifungal activity of silver nanoparticles and clotrimazole against Candida spp. Brazilian J. Pharm. Sci. 58, e18719 (2022).","journal-title":"Brazilian J. Pharm. Sci."},{"key":"52495_CR42","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/jof7090763","volume":"7","author":"FC Possamai Rossatto","year":"2021","unstructured":"Possamai Rossatto, F. C. et al. Antifungal activity of the phenolic compounds Ellagic Acid (EA) and Caffeic Acid Phenethyl Ester (CAPE) against drug-resistant Candida auris. J. Fungi 7, 763 (2021).","journal-title":"J. Fungi"},{"key":"52495_CR43","doi-asserted-by":"crossref","unstructured":"Jihene, A. et al. Antileishmanial Potential of Propolis Essential Oil and Its Synergistic Combination With Amphotericin B. Nat Prod. Commun 15\u00a0(2020).","DOI":"10.1177\/1934578X19899566"},{"key":"52495_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s42770-024-01591-9","volume":"56","author":"APC Bergamini","year":"2025","unstructured":"Bergamini, A. P. C. et al. Chemical profile, antioxidant, antifungal, and cytotoxic activities of propolis from the stingless bee Tetragona clavipes. Brazilian J. Microbiol. 56, 251\u2013262 (2025).","journal-title":"Brazilian J. Microbiol."},{"key":"52495_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/jof9040442","volume":"9","author":"A Arg\u00fcelles","year":"2023","unstructured":"Arg\u00fcelles, A. et al. Insight into the antifungal effects of propolis and carnosic acid\u2014extension to the pathogenic yeast Candida glabrata: new propolis fractionation and potential synergistic applications. J. Fungi 9, 442 (2023).","journal-title":"J. Fungi"},{"key":"52495_CR46","doi-asserted-by":"publisher","first-page":"e118022","DOI":"10.1590\/fst.118022","volume":"42","author":"RS MOREIRA","year":"2022","unstructured":"MOREIRA, R. S. et al. Preparation and evaluation of red propolis and nystatin cyclodextrin inclusion complexes against oral microbiome opportunistic microorganisms. Food Sci. Technol. 42, e118022 (2022).","journal-title":"Food Sci. Technol."},{"key":"52495_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1078\/0944-5013-00215","volume":"158","author":"S Stepanovi\u0107","year":"2003","unstructured":"Stepanovi\u0107, S., Anti\u0107, N., Daki\u0107, I. & \u0160vabi\u0107-Vlahovi\u0107, M. In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs. Microbiol. Res. 158, 353\u2013357 (2003).","journal-title":"Microbiol. Res."},{"key":"52495_CR48","doi-asserted-by":"publisher","unstructured":"Ho\u0142derna, E. & K\u0119dzia, B. Investigations upon the combined action of propolis and antimycotic drugs on Candida albicans. https:\/\/doi.org\/10.5555\/19900229481 (1987).","DOI":"10.5555\/19900229481"},{"key":"52495_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","volume":"10","author":"FB Cavassin","year":"2021","unstructured":"Cavassin, F. B., Ba\u00fa-Carneiro, J. L., Vilas-Boas, R. R. & Queiroz-Telles, F. Sixty years of Amphotericin B: An overview of the main antifungal agent used to treat invasive fungal infections. Infect. Dis. Ther. 10, 115\u2013147 (2021).","journal-title":"Infect. Dis. Ther."},{"key":"52495_CR50","doi-asserted-by":"publisher","DOI":"10.1057\/9781137377029","author":"A Homei","year":"2013","unstructured":"Homei, A. & Worboys, M. Fungal Disease in Britain and the United States 1850\u20132000. Fungal Dis. Br. United States https:\/\/doi.org\/10.1057\/9781137377029 (2013).","journal-title":"Fungal Dis. Br. United States"},{"key":"52495_CR51","doi-asserted-by":"publisher","first-page":"29276","DOI":"10.3389\/fmicb.2012.00286","volume":"3","author":"AC Mesa-Arango","year":"2012","unstructured":"Mesa-Arango, A. C., Scorzoni, L. & Zaragoza, O. It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug. Front. Microbiol. 3, 29276 (2012).","journal-title":"Front. Microbiol."},{"key":"52495_CR52","doi-asserted-by":"publisher","first-page":"112791","DOI":"10.1016\/j.jep.2020.112791","volume":"256","author":"JL Corr\u00eaa","year":"2020","unstructured":"Corr\u00eaa, J. L. et al. Propolis extract has bioactivity on the wall and cell membrane of Candida albicans. J. Ethnopharmacol. 256, 112791 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"52495_CR53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijmm.2017.03.005","volume":"307","author":"JP Guirao-Abad","year":"2017","unstructured":"Guirao-Abad, J. P., S\u00e1nchez-Fresneda, R., Alburquerque, B., Hern\u00e1ndez, J. A. & Arg\u00fcelles, J.-C. ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and micafungin in Candida albicans. Int. J. Med. Microbiol. 307, 241\u2013248 (2017).","journal-title":"Int. J. Med. Microbiol."},{"key":"52495_CR54","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1128\/EC.00256-10","volume":"10","author":"PA de Castro","year":"2011","unstructured":"de Castro, P. A. et al. Molecular characterization of propolis-induced cell death in Saccharomyces cerevisiae. Eukaryot. Cell 10, 398\u2013411 (2011).","journal-title":"Eukaryot. Cell"},{"key":"52495_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110435","volume":"129","author":"P Oki\u0144czyc","year":"2020","unstructured":"Oki\u0144czyc, P. et al. Antimicrobial activity of Apis mellifera L. and Trigona sp. propolis from Nepal and its phytochemical analysis. Biomed. Pharmacother. 129, 110435 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"52495_CR56","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/jam.12746","volume":"118","author":"B Pippi","year":"2015","unstructured":"Pippi, B. et al. In vitro evaluation of the acquisition of resistance, antifungal activity and synergism of Brazilian red propolis with antifungal drugs on Candida spp.. J. Appl. Microbiol. 118, 839\u2013850 (2015).","journal-title":"J. Appl. Microbiol."},{"key":"52495_CR57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/2047-783X-16-4-159","volume":"16","author":"G Kofla","year":"2011","unstructured":"Kofla, G. & Ruhnke, M. Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - Review of the literature. Eur. J. Med. Res. 16, 159 (2011).","journal-title":"Eur. J. Med. Res."},{"key":"52495_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1039\/C3NP70070D","volume":"31","author":"JM Balkovec","year":"2013","unstructured":"Balkovec, J. M. et al. Discovery and development of first in class antifungal caspofungin (CANCIDAS\u00ae): A case study. Nat. Prod. Rep. 31, 15\u201334 (2013).","journal-title":"Nat. Prod. Rep."},{"key":"52495_CR59","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3109\/13693780802552606","volume":"47","author":"J Kelly","year":"2009","unstructured":"Kelly, J., Rowan, R., Mccann, M. & Kavanagh, K. Exposure to caspofungin activates Cap and Hog pathways in Candida albicans. Med. Mycol. 47, 697\u2013706 (2009).","journal-title":"Med. Mycol."},{"key":"52495_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1128\/AAC.23.1.79","volume":"23","author":"AR Waldorf","year":"1983","unstructured":"Waldorf, A. R. & Polak, A. Mechanisms of action of 5-fluorocytosine. Antimicrob. Agents Chemother. 23, 79\u201385 (1983).","journal-title":"Antimicrob. Agents Chemother."},{"key":"52495_CR61","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2411.11060","volume":"35","author":"Y Huang","year":"2025","unstructured":"Huang, Y. et al. Aspirin combined with antifungal drugs suppresses Candida albicans biofilm by activating autophagy. J. Microbiol. Biotechnol. 35, e2411060 (2025).","journal-title":"J. Microbiol. Biotechnol."},{"key":"52495_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/app142411859","volume":"14","author":"P Mucha","year":"2024","unstructured":"Mucha, P., Borkowski, B., Erkiert-Polguj, A. & Budzisz, E. Ciclopirox and Ciclopirox Olamine: Antifungal agents in dermatology with expanding therapeutic potential. Appl. Sci. 14, 11859 (2024).","journal-title":"Appl. Sci."},{"key":"52495_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/pathogens7020056","volume":"7","author":"K Gucwa","year":"2018","unstructured":"Gucwa, K., Kusznierewicz, B., Milewski, S., van Dijck, P. & Szweda, P. Antifungal activity and synergism with azoles of polish propolis. Pathog 7, 56 (2018).","journal-title":"Pathog"},{"key":"52495_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1439-0507.1989.tb02293.x","volume":"32","author":"H Bossche","year":"1989","unstructured":"Bossche, H. et al. Biochemical approaches to selective antifungal activity:\u00a0Focus azole antifungals. Mycoses 32, 35\u201352 (1989).","journal-title":"Mycoses"},{"key":"52495_CR65","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02067-12","volume":"57","author":"AG Warrilow","year":"2013","unstructured":"Warrilow, A. G., Parker, J. E., Kelly, D. E. & Kelly, S. L. Azole affinity of sterol 14\u03b1-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens. Antimicrob. Agents Chemother. 57, 1352 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"52495_CR66","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","volume":"13","author":"D Allen","year":"2015","unstructured":"Allen, D., Wilson, D., Drew, R. & Perfect, J. Azole antifungals: 35 Years of invasive fungal infection management. Expert Rev. Anti Infect. Ther. 13, 787\u2013798 (2015).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"52495_CR67","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.4.501","volume":"12","author":"MA Ghannoum","year":"1999","unstructured":"Ghannoum, M. A. & Rice, L. B. Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12, 501 (1999).","journal-title":"Clin. Microbiol. Rev."},{"key":"52495_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/jof6010023","volume":"6","author":"SB Salazar","year":"2020","unstructured":"Salazar, S. B. et al. An overview on conventional and non-conventional therapeutic approaches for the treatment of candidiasis and underlying resistance mechanisms in clinical strains. J. Fungi 6, 23 (2020).","journal-title":"J. Fungi"},{"key":"52495_CR69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/IDR.S118892","volume":"10","author":"EL Berkow","year":"2017","unstructured":"Berkow, E. L. & Lockhart, S. R. Fluconazole resistance in Candida species: A current perspective. Infect. Drug Resist. 10, 237\u2013245 (2017).","journal-title":"Infect. Drug Resist."},{"key":"52495_CR70","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03526-23","author":"J Li","year":"2024","unstructured":"Li, J. et al. Upc2-mediated mechanisms of azole resistance in Candida auris. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/spectrum.03526-23 (2024).","journal-title":"Microbiol. Spectr."},{"key":"52495_CR71","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3109\/10715762.2014.953139","volume":"48","author":"J Krych","year":"2014","unstructured":"Krych, J., Gebicki, J. L. & Gebicka, L. Flavonoid-induced conversion of catalase to its inactive form-Compound II. Free Radic. Res. 48, 1334\u20131341 (2014).","journal-title":"Free Radic. Res."},{"key":"52495_CR72","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2023.2278937","volume":"15","author":"Q Jiang","year":"2023","unstructured":"Jiang, Q., Deng, Y., Li, S., Yang, D. & Tao, L. Sub-lethal concentrations of chlorhexidine inhibit Candida albicans growth by disrupting ROS and metal ion homeostasis. J. Oral Microbiol. 15, 2278937 (2023).","journal-title":"J. Oral Microbiol."},{"key":"52495_CR73","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1023\/A:1006852207366","volume":"140","author":"KH Abu-Elteen","year":"1997","unstructured":"Abu-Elteen, K. H. & Whittaker, P. A. Effect of sub-inhibitory concentration of chlorhexidine on lipid and sterol composition of Candida albicans. Mycopathologia 140, 69\u201376 (1997).","journal-title":"Mycopathologia"},{"key":"52495_CR74","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1034\/j.1601-0825.2001.70210.x","volume":"7","author":"S Anil","year":"2001","unstructured":"Anil, S., Ellepola, A. & Samaranayake1, L. The impact of chlorhexidine gluconate on the relative cell surface hydrophobicity of oral Candida albicans. Oral Dis. 7, 119\u2013122 (2001).","journal-title":"Oral Dis."},{"key":"52495_CR75","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00959-19","volume":"5","author":"PT LaBreck","year":"2020","unstructured":"LaBreck, P. T. et al. Systematic analysis of efflux pump-mediated antiseptic resistance in Staphylococcus aureus suggests a need for greater antiseptic stewardship. mSphere 5, e00959-19 (2020).","journal-title":"mSphere"},{"key":"52495_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010355","volume":"26","author":"MV Kuznetsova","year":"2025","unstructured":"Kuznetsova, M. V. et al. Nosocomial Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus: Sensitivity to Chlorhexidine-based biocides and prevalence of efflux pump genes. Int. J. Mol. Sci. 26, 355 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"52495_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165228","volume":"11","author":"S Langsrud","year":"2016","unstructured":"Langsrud, S. et al. Ethylhexylglycerin impairs membrane integrity and enhances the lethal effect of phenoxyethanol. PLoS One 11, e0165228 (2016).","journal-title":"PLoS One"},{"key":"52495_CR78","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/app14010115","volume":"14","author":"K G\u00f3rka","year":"2023","unstructured":"G\u00f3rka, K. & Kubi\u0144ski, K. Antifungal activity against human and plant mycopathogens, and green synthesis of silver nanoparticles exhibiting such activity. Appl. Sci. 14, 115 (2023).","journal-title":"Appl. Sci."},{"key":"52495_CR79","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.2174\/1389201024666230303145653","volume":"24","author":"JA Cervantes-Ch\u00e1vez","year":"2023","unstructured":"Cervantes-Ch\u00e1vez, J. A. et al. Biogenic Silver nanoparticles and stressors generate synergistic growth inhibition in Candida species through cell wall damage, osmotic stress, and oxidative stress. Curr. Pharm. Biotechnol. 24, 1682\u20131693 (2023).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"52495_CR80","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.2147\/IJN.S150648","volume":"13","author":"VS Radhakrishnan","year":"2018","unstructured":"Radhakrishnan, V. S. et al. Silver nanoparticles induced alterations in multiple cellular targets, which are critical for drug susceptibilities and pathogenicity in fungal pathogen Candida albicans. Int. J. Nanomed. 13, 2647\u20132663 (2018).","journal-title":"Int. J. Nanomed."},{"key":"52495_CR81","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10534-008-9159-2","volume":"22","author":"KJ Kim","year":"2009","unstructured":"Kim, K. J. et al. Antifungal activity and mode of action of silver nano-particles on Candida albicans. BioMetals 22, 235\u2013242 (2009).","journal-title":"BioMetals"},{"key":"52495_CR82","first-page":"453","volume":"65","author":"SO Mohamed","year":"2022","unstructured":"Mohamed, S. O., El-Naggar, K. & Khalil, M. M. H. Green synthesis of silver nanoparticles using Egyptian propolis extract and its antimicrobial activity. Egypt. J. Chem. 65, 453\u2013464 (2022).","journal-title":"Egypt. J. Chem."},{"issue":"9","key":"52495_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/CBDV.202402348","volume":"22","author":"E Tirzah","year":"2025","unstructured":"Tirzah, E. et al. Green propolis extract-mediated synthesis of biogenic silver nanoparticles: In vitro antileishmanial and antibacterial activities, cytotoxicity and ex vivo irritation testing. Chem. Biodivers. e202402348. https:\/\/doi.org\/10.1002\/CBDV.202402348 (2025).","journal-title":"Chem. Biodivers."},{"key":"52495_CR84","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2217\/fmb-2019-0173","volume":"15","author":"B Kischkel","year":"2020","unstructured":"Kischkel, B. et al. Silver nanoparticles stabilized with propolis show reduced toxicity and potential activity against fungal infections. Future Microbiol. 15, 521\u2013539 (2020).","journal-title":"Future Microbiol."},{"key":"52495_CR85","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/IJN.S93611","volume":"11","author":"A Krolicka","year":"2016","unstructured":"Krolicka, A. et al. Synthesis of antimicrobial silver nanoparticles through a photomediated reaction in an aqueous environment. Int. J. Nanomed. 11, 315 (2016).","journal-title":"Int. J. Nanomed."},{"key":"52495_CR86","unstructured":"Barbara, D. et al. M. CLSI M27 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts Approved Guideline. USA (2004)."},{"key":"52495_CR87","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1128\/AAC.46.10.3323-3326.2002","volume":"46","author":"J Afeltra","year":"2002","unstructured":"Afeltra, J., Dannaoui, E., Meis, J. F. G. M., Rodriguez-Tudela, J. L. & Verweij, P. E. In vitro synergistic interaction between Amphotericin B and Pentamidine against Scedosporium prolificans. Antimicrob. Agents Chemother. 46, 3323\u20133326 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"52495_CR88","unstructured":"Eliopoulos, G. M. & Moellering, R. C. Antimicrobial combinations. In Antibiotics in Laboratory Medicine (Lippincott Williams & Wilkins, 1996)."},{"key":"52495_CR89","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","volume":"137","author":"MC Berenbaum","year":"1978","unstructured":"Berenbaum, M. C. A method for testing for synergy with any number of agents. J. Infect. Dis. 137, 122\u2013130 (1978).","journal-title":"J. Infect. Dis."},{"key":"52495_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00229","author":"A Wozniak","year":"2019","unstructured":"Wozniak, A., Rapacka-Zdonczyk, A., Mutters, N. T. & Grinholc, M. Antimicrobials are a photodynamic inactivation adjuvant for the eradication of extensively drug-resistant Acinetobacter baumannii. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2019.00229 (2019).","journal-title":"Front. Microbiol."},{"key":"52495_CR91","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10482-009-9394-8","volume":"97","author":"RS Iwazaki","year":"2009","unstructured":"Iwazaki, R. S. et al. In vitro antifungal activity of the berberine and its synergism with fluconazole. Antonie van Leeuwenhoek 97, 201\u2013205 (2009).","journal-title":"Antonie van Leeuwenhoek"},{"key":"52495_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103442","volume":"9","author":"W Liu","year":"2014","unstructured":"Liu, W. et al. Synergistic antifungal effect of glabridin and fluconazole. PLoS One 9, e103442 (2014).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52495-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52495-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52495-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:01:14Z","timestamp":1783904474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52495-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52495"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52495-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2026.04.21.719917","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21763"}}